Delving into the Latest Updates on Maqin Granules with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Immune System DiseasesInfectious DiseasesRespiratory Diseases

Active Indication

Common ColdCoughCough variant asthma

Inactive Indication-

Originator Organization

Sichuan Academy of Chinese Medicine Sciences

Active Organization

Sichuan Academy of Chinese Medicine Sciences

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

1. 探索麻芩颗粒改善感冒后咳嗽症状的有效性； 2. 探索麻芩颗粒改善咳嗽变异性哮喘症状的有效性； 3. 探索麻芩颗粒改善感冒后咳嗽、咳嗽变异性哮喘（风邪犯肺、肺气失宣证）的作用； 4. 观察麻芩颗粒的安全性及不良反应。

[Translation]

1. To explore the effectiveness of Maqin Granules in improving cough symptoms after cold; 2. To explore the effectiveness of Maqin Granules in improving cough variant asthma symptoms; 3. To explore the role of Maqin Granules in improving cough after cold and cough variant asthma (wind evil invading the lungs, lung qi failure to vent syndrome); 4. To observe the safety and adverse reactions of Maqin Granules.

Start Date-

Sponsor / Collaborator

Sichuan Academy of Chinese Medicine Sciences

100 Clinical Results associated with Maqin Granules

Login to view more data

100 Translational Medicine associated with Maqin Granules

Login to view more data

100 Patents (Medical) associated with Maqin Granules

Login to view more data

100 Deals associated with Maqin Granules

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Common Cold	Phase 2	China	Sichuan Academy of Chinese Medicine Sciences	12 Apr 2019
Cough	Phase 2	China	Sichuan Academy of Chinese Medicine Sciences	12 Apr 2019
Cough variant asthma	Phase 2	China	Sichuan Academy of Chinese Medicine Sciences	12 Apr 2019